Chemed (CHE) director Patrick P. Grace plans 223-share stock sale in Form 144
Rhea-AI Filing Summary
Chemed Corporation insider Patrick P. Grace has filed to potentially sell capital stock under a Form 144. The filing lists a planned sale of 223 shares of capital stock, with an aggregate market value of $119,258, to be sold through J.P. Morgan Securities LLC on or after July 31, 2026 on the NYSE.
The form also notes that during the prior three months, Grace sold 60 shares of capital stock on May 10, 2026 for total proceeds of $25,547. The securities relate to director compensation.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 223 shares
Aggregate market value of planned sale: $119,258
Planned sale date: 07/31/2026
+2 more
5 metrics
Planned shares to be sold
223 shares
Capital stock to be sold through J.P. Morgan Securities LLC
Aggregate market value of planned sale
$119,258
Planned sale of 223 shares of capital stock
Planned sale date
07/31/2026
Approximate date for sale of 223 shares on the NYSE
Shares sold in past 3 months
60 shares
Capital stock sold on 05/10/2026
Proceeds from prior sale
$25,547
Sale of 60 shares of capital stock on 05/10/2026
Key Terms
Form 144, capital stock, director compensation
3 terms
Form 144 regulatory
"Patrick P. Grace has filed to potentially sell capital stock under a Form 144"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
capital stock financial
"The filing lists a planned sale of 223 shares of capital stock"
Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.
director compensation financial
"The securities relate to director compensation"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Chemed (CHE) insider Patrick P. Grace report in this Form 144?
Patrick P. Grace reports a planned sale of 223 shares of Chemed capital stock, with an aggregate market value of $119,258, to be sold through J.P. Morgan Securities LLC on or after July 31, 2026.
Which broker is named for the Chemed (CHE) Form 144 stock sale?
The filing names J.P. Morgan Securities LLC as the broker for the planned sale of Chemed capital stock. The shares are expected to be sold on the NYSE on or after July 31, 2026.
How are the Chemed (CHE) securities characterized in this Form 144 filing?
The securities are described as capital stock related to director compensation. The Form 144 reflects both the planned sale of 223 shares and a prior sale of 60 shares within the last three months.